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Abstract 
A number of evidence-based weight management interventions are now available with different models, 
and serving different patient/client groups.  While positive outcomes are key to the decision making 
process, so too is the information around how these outcomes were achieved, in what population, how 
transferable the outcomes would be to the population a service would be aiming to cover and at what cost 
to the service-provider and or the individual. This paper examines all the UK interventions with recent 
peer-reviewed evidence of their effectiveness in “realistic” settings and cost-effectiveness, in the context 
of NICE and SIGN guidelines.  It concludes that the evidence-based approaches allow intervention at 
different stages in the disease-process of obesity which are effective in different settings.  Self-referral to 
commercial agencies, by individuals with relatively low BMI and few medical complications is a 
reasonable first step.  For more severely obese individuals (e.g. BMI >35kg/m2) requiring more medically 
complicated care, evidence is largely lacking for these services, but the community-based Counterweight 
Programme is effective and cost-effective in maintaining weight loss >5kg up to 2 years for 30-40% of 
attenders.  For more complicated and resistant obesity, referral to a secondary care-based service can 
generate short-term weight loss, but 12 months data are unavailable.  
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Introduction 
The needs of patients and taxpayers are best served if diseases are managed using evidence-based and 
cost-effective methods,  Evidence-based clinical guidelines for obesity and weight management are now 
well established by The Scottish Intercollegiate Guideline Network (SIGN) (1996 and 2010)  in Scotland, 
The National Institute of Health and Clinical Excellence (NICE) in England (2006) and in many other 
countries1,2,3.  United Kingdom (UK) guidelines have noted that many of the studies on interventions were 
conducted outside the UK, were of short duration, with little or no follow-up, and were poorly reported.  
NICE has called for studies of interventions with a minimum of 12 months follow up.   Recognising the 
scale and epidemic nature of obesity, its costs to society, the somewhat chaotic management existing 
within the UK National Health Service (NHS), and the failure hitherto of any population-based prevention 
strategy, these Guideline documents have highlighted the need to create effective treatment services in 
parallel with effective preventive interventions.   
There are several emerging issues for primary care and community-based clinical weight management in 
the United Kingdom (UK).  Firstly, the Department of Health “Call to Action on Obesity” in England set a 
target to reduce the proportion of adults with excess weight by 20204. Noting that since prevention has 
hitherto failed, with the majority, two-thirds of UK adults now overweight or obese, effective treatment 
programmes will be increasingly important.  Care is currently purchased at local, PCT level in England, 
moving to local commissioning boards in 2013, and in 2011 the Scottish Government also decided to 
devolve budgetary responsibility to Health Boards to put in place appropriate weight management 
interventions.   While different local solutions are possible, the choice of intervention must evaluate the 
disease-burden and costs of rising obesity, particularly of severe obesity (e.g. BMI >40, >50, >60) rising 
most rapidly and the proven effectiveness of interventions in meeting targets such as those set out in the 
Department of Health Call to Action, in relation to available local funding.  
The present paper reviews recent peer-reviewed evidence on diet and lifestyle-based weight 
management programmes widely available for use in the UK in primary care/ community settings, in 
relation to the points made by NICE (2006) outlined above.   While the need for new and different 
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therapies is recognised, guidelines stress the primary role of primary care/ community-based 
interventions because of sheer numbers of potential patients.  This paper excludes studies of adjunctive 
treatments with pharmacotherapy, liquid-diet programmes, meal-replacement therapies and secondary 
care programmes such as bariatric surgery. 
Historically, most published research in weight management has been on pharmaceutical trials or 
research-centre based interventions. More recently there have been publications from large-scale primary 
care/ community-based weight management services for adults, in what can be considered realistic 
settings or within routine care.  The results published have varied somewhat, leading to commentaries 
which have tried to rank them5.  That ranking process has not always recognised that the interventions as 
reported were developed for different reasons, and applied to different populations in different settings.  
Thus simple comparisons of reported “top-line” results can be misleading.  We have attempted to 
evaluate the recently published programmes in terms of their contexts as well as weight change 
outcomes, in order to clarify their different roles within improved overall weight management services. 
 
Aim: this review evaluates published evidence on UK primary care/ community-based weight 
management intervention assessed in ‘realistic’ settings, focusing on effectiveness and cost-effectiveness 
of available interventions, the different population served/covered by different interventions, and the 
limitations of the available interventions. 
 
Methods and data sources 
The literature was searched to reach the totality of relevant evidence within the very restricted nature of 
this paper, which focuses on studies conducted within the UK only, in realistic settings and with at least 
12-months follow-up data.  A modified systematic approach was therefore used where a PUBMED search 
was conducted on 26 March 2012 using the following search terms: ‘obesity’, ‘adults’, ‘UK’, ‘intervention’, 
‘programme’  and with publication date after January 2005.  The cut off for papers published after January 
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2005 was used to include current research which would not have featured in the NICE Guidelines on 
Obesity from 20062 but should reflect programmes which adhere to national guidance around weight 
management as provided in SIGN 19961.  We are not aware of any older publications on available, 
evidence-based programmes. The search was not restricted to randomised controlled trial evidence, 
recognising that programmes which incorporate evaluation by closed-loop audit and Continuous 
Improvement Methodology can be equally valid for service development.  Twenty nine papers were 
identified of which n=1 was rejected as being qualitative research only, n=3 were rejected as reviews, n=5 
rejected as focused on children, n=4 rejected as presenting trial design only, n=1 rejected as included 
meal replacement therapy, n=1 rejected as focused only on physical activity outcomes, n=3 rejected as 
secondary analyses focused on the burden of obesity, and n=6 rejected because weight change data 
were not included or the focus of the study. Of the remaining 5 papers only 2 presented 12-month 
outcomes, despite the recommendation by NICE in 2006 to focus on trials with results at a minimum of 
12-months.  Recognising the difficulties of generating reliable 12-month interventional data, we also 
included the Lighten-Up study giving three suitable publications: Counterweight, Weight Watchers, and 
Lighten-Up6,7,8 and we have commented on shorter term studies in the discussion.  
 
Results 
All the publications included demonstrate that clinically beneficial weight change can be achieved for a 
valuable proportion of patients, through a variety of programme components and with variable resource 
implications. The programmes which have been reviewed involved groups of obese patients with rather 
different characteristics, and thus serve somewhat different purposes so direct comparison of “top line” 
weight change results would be misleading.  Key data are presented in Tables 1 and 2. 
Counterweight: Care is delivered by existing non-specialist staff, such as practice nurses or health care 
assistants/ support workers, after brief training and then on-the-job mentoring by Counterweight specialist 
staff.  Patients do not pay for the service.  This intervention represents a first level of NHS intervention, in 
primary care, or local pharmacies: 12-month weight-change results are identical whether the programme 
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is delivered by practice nurses or pharmacy staff9.  Baseline mean BMI of the patients enrolled is high, at 
37kg/m2 and 14% have diabetes which is known to impede weight loss on conventional diets (table 1).  A 
high proportion of Counterweight subjects have other obesity-related clinical problems including 
limitations on physical activity, and many are from high-deprivation backgrounds. The patients are mainly 
enrolled through general practice referral.  Retention in the programme is maintained at 3, 12 & 24 
months at around half of those entering, with similar weight losses (median ~3kg loss) and similar % 
exceeding 5% loss ~25-30% at each of these times. An important aspect of the Counterweight patient-
population is the high prevalence of associated co-morbid conditions, whose management tends to 
compete for attention by both staff and patients.   The sustained results of Counterweight depend on 
availability of a small core of Counterweight Specialist staff, to train and mentor non-specialists in 
programme delivery, adequately resourced non-specialist staff to deliver the programme and on the 
ongoing central data collection and analysis, with regular feedback of results to Health Boards, GP 
practices and other programme delivery services. The flexibility of one to one or group delivery allows the 
patient and staff to decide which option best suits. 
Weight Watchers: A commercial community-based organisation run by non-health-professionals and 
delivered in groups, which might be regarded as the first option for an obese person seeking help outside 
medical services. Twelve month data (table 1) are reported on 230 individuals (from 3 countries: UK, 
Australia and Germany) referred from Primary Care, who, unlike usual care Weight Watchers clients, did 
not pay for the service.  Mean baseline BMI is lower than for other published programmes at 31 kg/m2. 
Outcomes are positive with 61% remaining on the programme for 12 months and lose a mean 6.6kg.  The 
socioeconomic profile of the subjects, which can affect success, is not provided, so these good results 
may not apply to all patients in all areas e.g. may be less positive in areas of high social deprivation.  With 
the lower BMI, few patients had T2DM, which impedes weight loss with conventional diets6.  An important 
detail, when considering outcomes, is the number of contacts available to individuals for the Weight 
Watchers RCT UK trial; 36 free Weight Watchers group sessions in 12 months. The resource available to 
reflect this level of intervention needs to be considered along with individuals’ ability or willingness to pay 
for intervention. 
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Lighten Up: This study compared results from obese patients recruited from Primary Care through 
invitation letters sent by the patients general practitioner and randomised to one of 3 commercial club 
programmes (Weight Watchers, Slimming World and Rosemary Conley), or managed through NHS, in 
General Practice  or pharmacies. Due to the complexity of this study (8 arms in total) we have 
summarised the data in Table 2. 
In the Lighten Up Study, numbers with 12month data (excluding self-reported data) are very limited 
ranging from 32/70 (45%) in the pharmacy arm to 67/ 100 (67%) in the Weight Watchers arm. Of note 
when considering wider application to routine care is that only 8.3% of the obese subjects approached 
agreed to take part in the study. Of the 1011 recruited to the study 12m follow up is reported for 522 
(52%) but only 416 (41%) had follow up weights measured: the remaining 106 providing self-reported 
weights. This study (albeit with limited numbers) confirms the effectiveness of commercial organisations 
for at least some subjects with a lower BMI. However a critical detail, missing from the published data, is 
information on the proportion of the people allocated to a commercial slimming group arm of the trial who 
continued attendance (by paying to attend additional sessions) with the allocated group beyond the study 
sessions. This detail is needed to see the actual number of attendances required to result in the reported 
weight change.  
 
While poor attendance appears to impair outcomes for the primary care programmes, there is limited 
detail about the attendance at commercial slimming groups. Retention rates were low in both general 
practice and pharmacy arms of the Lighten Up study (see table 2): the factors affecting retention rates are 
worthy of further scrutiny.  Baseline data indicated a reasonable percentage of men entered the 
programme which is encouraging, but it is not clear if patient retention was equal between the sexes.  
Further detail of the exact programmes would be of value, in particular how the general practice staff 
were trained or mentored and whether or how programme integrities were assessed. 
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Services with only short-term published data 
NICE recommended in 2006 that 12-month outcomes were essential in weight management intervention 
outcomes. Programmes which achieve only short-term weight loss are unlikely to provide good value for 
money.   A number of Programmes available in UK primary care/ community settings have published 
short term outcomes. While of interest, the results and clinical benefits of these interventions must be 
treated with caution while longer term peer reviewed data is awaited. 
The GCWMS:  We have included published data from the Glasgow & Clyde Weight Management Service 
(GCWMS) which serves almost a quarter of the population of Scotland10. We have discussed this in depth 
because of its scale, and because there is no other published example of a routine service which caters 
for severe and complicated obesity in a specialist service or what is frequently referred to as “Tier 3”.  
This intervention involves direct patient contact, in groups of non-paying NHS patients, with a range of 
highly qualified specialist staff; in central specialist care setting.  It represents a second level of NHS 
obesity management.  GCWMS serves patients with a high prevalence of poor socioeconomic 
backgrounds, and high mean BMI with 52% >40kg/m2.  It thus addresses a more advanced stage of 
obesity which is strikingly more prevalent in more deprived socio-economic and geographical groups11: 
the proportion of T2DM (around 1 in 6) is similar to that in Counterweight6.  At this stage only 16 week 
data are available, and baseline weight, BMI and age distributions are not clearly provided.  The 12 week 
outcomes show that 36% of the attending population lost >5kg.  This result needs to be interpreted in light 
of the much higher baseline BMI, so loss of 5kg does not equal 5%. Also many studies, such as 
Counterweight, have demonstrated that greater absolute weight loss is achieved by those with higher 
BMI6.   The GCWMS goal of >5kg weight loss may not be sufficient for functional improvement in patients 
with BMI >40 kg/m2, and falls short of the target of 15% loss more recently set by SIGN guideline 115 
(2010)1.  The lack of 12 month data so far does not allow any conclusions to be drawn about weight loss 
maintenance, or for any direct comparison with the other programmes. 
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Slimming World: published 12-week data on 34,271 individuals: 89% female. Mean BMI = 36.8kg/m2. 
56% completed the programme. Mean weight change at 12 weeks = 5.5kg (5.5%) loss. No 12m data are 
available for review to assess maintenance12.  
Internet Based Delivery: 70 patients of 103 entered into the intervention programme (71 (69%) female) 
achieved loss of 3.5kg loss at 6months. Entry criteria was BMI>28kg/m2. Weight change was self reported 
so outcomes need to be interpreted with caution. No 12month data are available for review to assess 
maintenance13. 
Weight-management interventions in primary care: a pilot randomised controlled trial: Reported 
data on 123 adults: 80.3% women, BMI>27kg/m2, 103 (84%) provided data at 12 weeks. Mean difference 
in weight in structured support compared to usual care groups was -2.63 kg. 34% in structured groups 
lost >5% compared with 20% in usual care groups. No 12month are data available to assess 
maintenance14. 
  
Discussion 
This brief review of the evidence-based programmes available for adults  in UK indicates that they all 
generate valuable weight loss, and those with 12 month data are also able to maintain that loss for a 
reasonable proportion of patients.  However, the different programmes serve different aspects of weight 
management at different stages of patient need.  A direct comparison between the weight-change results 
of the programmes is not appropriate without considering their settings and the patient groups enrolled.  
The methods of outcome ascertainment also varied.  There is thus no single ‘best option’ amongst the 
evidence-based programme, for weight management in primary care/ community settings.   Given the 
scale of the obesity epidemic and range of degrees to which individuals are affected by obesity, care-
providers will need a menu of options for optimal weight management in adults.  Future studies are 
needed to identify the most cost-effective approaches for heterogeneous populations requiring weight 
management at different stages, and randomised trials may not provide the best or most needed 
evidence15,16. 
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Health Economic analysis 
Counterweight remains the only service to have published a full Health Economics analysis of cost per 
Quality Adjusted Life Year, which showed very high cost-effectiveness for its conventional diet and 
lifestyle-based programme 17.  A cost in the region of £100 per patient was achieved by providing training 
for non-specialist staff, who then deliver the structured programme to patients. The weight change 
achieved would be considered clinically important, and cost-effective at a population level with potential to 
delay clinical problems aggravated by obesity, and thus cost avoidance.   
In the Counterweight Health Economic analysis a conservative estimate of the likely clinical benefits from 
the relatively modest weight losses achieved and maintained was made, using the NICE predictive 
model: the model only considers the impact of weight change on three clinical areas, although robust 
evidence exists around the impact of weight on many more clinical problems.  In the long term it is clear 
that the NHS would generate substantial cost-savings if weight management solutions with robust 
evidence of effectiveness at 12 months such as Counterweight were established sustainably to ensure 
access to appropriate weight management intervention with 100% coverage across the UK (long-term 
cost avoidance would be greater than the short-term set-up and implementation costs).17   It is possible 
that a cost-effectiveness analysis of Weight Watchers, Rosemary Conley, Slimming World and GCWMS 
might produce similar results, although setting up specialist facilities such as GCWMS would entail much 
greater initial costs and evidence from Weight Watchers does point to a much greater reliance on 
attendance at the group sessions which would either need to be paid for by the public purse or by the 
individual attending.  
The challenges we face are firstly to improve the success rates of existing services, for example through 
Continuous Improvement Methodology, and secondly to provide a new and effective service for patients 
who fail in first-line treatment.  Continuous Improvement Methodology ensures a dynamic approach to 
provision of care, by incorporating evaluation and feedback from patients and clinicians as well as 
embedding relevant external advancements in care based on up to date research. The model fits with 
others such as the Evidence-Based Quality Assessment (EBQA) proposed by the Evidence-Based 
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Medicine Working Group (1992).  EBQA consists of four steps to improve physician adherence to 
guidelines: (1) setting priorities (2) setting guidelines (3) measuring performance and (4) improving 
performance.  Each phase of the Counterweight Programme Continuous Improvement Methodology fits 
with one of these four steps in the EBQA model18. 
Most analyses indicate that keeping patients engaged in a programme, and attending an optimal number 
of planned appointments is key to greater success 6,8.  Interventions need to meet the wishes and 
expectations of patients, as well as of referring doctors and those actually delivering and those funding 
the intervention.   
Central to overcoming the obesity epidemic is a need to de-mystify obesity and weight loss, and to 
penalise agencies which purport to offer effective products or services without externally validated 
evidence that is in the public domain.  Quoting average weight-losses based only on “completers” or 
“attenders” data, for example, can be helpful but only when put in context by also providing retention 
rates.  Anecdotal data must be treated with great caution.  While individual case studies can provide a 
personal and perhaps eye-catching story, but usually to reflect ‘best-case scenarios’. Data on outcomes 
with no detail of loss to follow up may be hiding poor retention and wasted resources.  Even with the best 
service, 20-40% of patients will discontinue, over 12 months and they generate costs.  Services which are 
promoted on the basis of data from “completers” only should be disregarded. 
 
Conclusion 
The published evidence suggests that a range of interventions are effective for weight management at 
different stages in the patient/client pathway, with 10-20% of entered patients able to maintain >5kg 
weight loss at 12 months.  Self-referral to commercial agencies, by individuals with relatively low BMI and 
few medical complications is a reasonable first step.  For more severely obese individuals (e.g. BMI 
>35kg/m2) requiring more medically complicated care, evidence is largely lacking for these services, but 
the community-based Counterweight Programme is effective and cost-effective in maintaining weight loss 
12 
 
>5kg up to 2 years for 30-35% of attenders.  For more complicated and resistant obesity, referral to a 
secondary care-based service can generate short-term weight loss, but 12 months and longer data are 
unavailable.  Newer services are in development and the primary-care based Counterweight Low Energy 
Liquid Diet programme has shown >15kg weight loss, maintained at 12 months for 33% of all patients and 
44% of those followed up at 12months19. These options should all be considered, with available 
pharmacotherapy when indicated, before referral for bariatric surgery. 
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Table 1 - Primary Care Counterweight & Weight Watchers 
 Counterweight Weight Watchers 
Programme Summary  
 
 
 
Modalities 
 
Target/ success criteria 
Visits/attendances 
Formed in 2000. Delivery by primary care 
and pharmacy support staff. Training and 
mentoring provided by trained 
Counterweight  detitians/nutritionists.  
Diet and physical activity lifestyle changes 
underpinned by behavioural therapy  
>5% weight loss and maintenance at 12m 
9 visits  over 12 months (publication 
outcomes mean contacts = 8 in 12m) 
Formed in 1963. Coverage in 30 
countries. Group delivery, by non-
health-professional counsellor 
 
Diet, behaviour & exercise advice. On 
line support 
BMI normalisation 
Weekly (RCT cites 36 visits in 12m) 
Published 2008 2011 
Study type Realistic single sample ITT analysis RCT 
Patients recruited (intervention )  
% completing  3 months 
% completing 12 months 
1906 
55% 
45% 
377 (UK only data ~120) 
- 
61% 
Baseline characteristics: 
a) Age (mean) 
b) Sex (% female) 
c) Mean BMI kg/m2 
d) % BMI>40 
e) % diabetic 
f) Socioeconomic s 
g) Exclusions 
 
a) 49 
b) 75% 
c) 37 
d) 25% 
e)14% 
f) 36% from high deprivation 
g) none stated 
 
a) 46 
b) 88% 
c) 31 
d) 0 (upper  BMI = 35kg/m2) 
e) 6% 
f) not stated 
g) multiple 
3m weight change 
(completers) 
a) Mean loss (kg) 
b) % with >5%/5kg 
 
a) 3.34kg 
b) 26% 
 
a) - 
b)- 
12m weight change 
(completers) 
a) Mean loss (kg) 
b) % with >5%/5kg 
c) ITT >5% 
 
a) 3.0kg 
b) 31% 
c) 13.9 
 
a) 6.6kg 
b)60% 
c)46% 
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Table 2.   Lighten Up Study Arms (100 patients offered randomisation to each arm) 
 Weight 
Watchers 
Slimming 
World 
Rosemary 
Conley 
NHs Size 
Down 
General 
Practice 
Pharmacy Choice Minimal 
Intervention 
Comparator 
Patients accepting 
recruitment option 
% complete @  3m* 
% complete @12m* 
91 
 
66 
74 
87 
 
63 
57 
84 
 
64 
67 
74 
 
57 
74 
88 
 
21 
41 
73 
 
42 
44 
95 
 
68 
65 
67 
 
43 
86 
Base char (alloc’d): 
a) Age (mean) 
b) Sex (% F) 
c) Mean BMI 
kg/m2 
d) % BMI>40 
e) % diabetic 
f) Mean IMD 
g) Exclusions 
 
a) 50.7 
b) 72 
c) 33.9 
 
d) 8 
e) NS 
f) 31 
g) NS 
 
a) 48.8 
b) 65 
c) 33.8 
 
d) 5 
e) NS 
f) 33.3 
g) NS 
 
a) 49.8 
b) 69 
c) 33.3 
 
d) 4 
e) NS 
f) 35.8 
g) NS 
 
a) 48.7 
b) 64 
c) 33.8 
 
d) 5 
e) NS 
f) 32.5 
g) NS 
 
a) 50.5 
b) 77 
c) 33.1 
 
d) 2 
e) NS 
f) 32.2 
g) NS 
 
a) 48.9 
b) 81 
c) 33.4 
 
d) 3 
e) NS 
f) 35.1 
g) NS 
 
a) 47.4 
b) 70 
c) 33.4 
 
d) 4 
e) NS 
f) 31.7 
g) NS 
 
a) 49.7 
b) 75 
c) 33.9 
 
d) 6 
e) NS 
f) 30.5 
g) NS 
3m weight change 
(completers) 
Mean loss (kg) 
% with >5% (ITT) 
 
5.15 
46.0 
 
 
4.25 
35.0 
 
5.29 
42.0 
 
3.22 
18.0 
 
2.17 
15.7 
 
 
2.8 
21.4 
 
3.81 
35.0 
 
2.96 
22.0 
12m weight change 
(completers) 
Mean loss (kg) 
% with >5% (ITT) 
 
 
4.4 
31.0 
 
3.1 
21.0 
 
3.3 
26.0 
 
3.7 
21.0 
 
1.3 
15.7 
 
1.2 
14.3 
 
 
2.9 
28.0 
 
 
1.1 
17.0 
*only actual weights at follow up rather than self reported 
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Table 3:  Selecting Weight Management Solutions  
When deciding on suitable solutions for weight management, published programmes should be considered with the following points derived from 
SIGN 2010 and NICE 2006. 
1. The representativeness of the study population, or specific sector swerved 
2. Only robust measures of outcome should be accepted i.e. measured not self-reported 
3. Weight loss results can be assessed at 3-6 months, but need to be supported by effective 
weight maintenance with 12-24 month data  
4. Consider differences in baseline characteristics in particular data on sex distribution, social 
deprivation, and prevalence of co-morbidities. 
5. Programme uptake and retention should be considered, presenting ITT data.  
6. The degree of programme flexibility and availability of patient choice  
7. Practical details of interventions are required to enable there repetition.  
8.  Economic analysis and long term health outcomes, or projected outcomes 
9. Appropriateness of stated weight loss targets to patient characteristics, e.g. presence of 
medical complications 
 
